These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 22710483)
1. Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Turkbey EB; Gai N; Lima JA; van der Geest RJ; Wagner KR; Tomaselli GF; Bluemke DA; Nazarian S Heart Rhythm; 2012 Oct; 9(10):1691-7. PubMed ID: 22710483 [TBL] [Abstract][Full Text] [Related]
2. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality. Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780 [TBL] [Abstract][Full Text] [Related]
3. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study. Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704 [TBL] [Abstract][Full Text] [Related]
5. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease. Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447 [TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257 [TBL] [Abstract][Full Text] [Related]
7. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy. Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920 [TBL] [Abstract][Full Text] [Related]
8. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance. Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674 [TBL] [Abstract][Full Text] [Related]
9. Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique. Nii M; Ishida M; Dohi K; Tanaka H; Kondo E; Ito M; Sakuma H; Ikeda T J Cardiovasc Magn Reson; 2018 Aug; 20(1):52. PubMed ID: 30068369 [TBL] [Abstract][Full Text] [Related]
10. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study. Donekal S; Venkatesh BA; Liu YC; Liu CY; Yoneyama K; Wu CO; Nacif M; Gomes AS; Hundley WG; Bluemke DA; Lima JA Circ Cardiovasc Imaging; 2014 Mar; 7(2):292-302. PubMed ID: 24550436 [TBL] [Abstract][Full Text] [Related]
11. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides. Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133 [TBL] [Abstract][Full Text] [Related]